Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA DIRECT-TO-CONSUMER BROADCAST GUIDANCE TO BE EVALUATED AFTER TWO YEARS; "ADEQUATE PROVISION" OF LABELING POSSIBLE THROUGH FOUR-PART APPROACH

Executive Summary

FDA will re-examine its direct-to-consumer broadcast policy in two years to assess the effect of its proposal to relax the brief summary requirement in TV and radio ads, the agency said in an Aug. 8 Federal Register notice.

You may also be interested in...



DTC Decennial Survey: FDA Adds Nurses, Physician Assistants To Queries On Ads

The survey will update findings from a 2002 assessment by physicians on the impact of DTC marketing on their interactions with patients.

Risk Disclosure In Drug Ads Will Be FDA’s Focus After House Defeats DTC Ban

The revised language on direct-to-consumer advertising in the FDA safety bills pending in Congress no longer allows the agency to ban ads, but creates a number of new disclosure requirements for the spots

Risk Disclosure In Drug Ads Will Be FDA’s Focus After House Defeats DTC Ban

The revised language on direct-to-consumer advertising in the FDA safety bills pending in Congress no longer allows the agency to ban ads, but creates a number of new disclosure requirements for the spots

Related Content

UsernamePublicRestriction

Register

PS030645

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel